Monoclonal antibody therapies in leukemias
Data up to Jan 2025
Total Citations Per Year
Abstract
References (34)
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.
1998 • 2,777 citations
Efficacy and Safety of Gemtuzumab Ozogamicin in Patients With CD33-Positive Acute Myeloid Leukemia in First Relapse
2001 • 877 citations
Cytokine-Release Syndrome in Patients With B-Cell Chronic Lymphocytic Leukemia and High Lymphocyte Counts After Treatment With an Anti-CD20 Monoclonal Antibody (Rituximab, IDEC-C2B8)
1999 • 653 citations
IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma.
1997 • 638 citations
Rituximab Dose-Escalation Trial in Chronic Lymphocytic Leukemia
2001 • 603 citations
Calicheamicin γ 1 I : an Antitumor Antibiotic That Cleaves Double-Stranded DNA Site Specifically
1988 • 548 citations
Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia. European Study Group of CAMPATH-1H Treatment in Chronic Lymphocytic Leukemia.
1997 • 531 citations
Rituximab Using A Thrice Weekly Dosing Schedule in B-Cell Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma Demonstrates Clinical Activity and Acceptable Toxicity
2001 • 521 citations
Efficacy of the Anti-CD22 Recombinant Immunotoxin BL22 in Chemotherapy-Resistant Hairy-Cell Leukemia
2001 • 514 citations
Fludarabine: a new agent with major activity against chronic lymphocytic leukemia
1989 • 466 citations
A monoclonal antibody reactive with normal and leukemic human myeloid progenitor cells
1984 • 420 citations
Rituximab therapy of patients with B-cell chronic lymphocytic leukemia
2001 • 354 citations
Targeting of the CD33-calicheamicin immunoconjugate Mylotarg (CMA-676) in acute myeloid leukemia: in vivo and in vitro saturation and internalization by leukemic and normal myeloid cells
2001 • 332 citations
High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H
2001 • 309 citations
Mylotarg? (gemtuzumab ozogamicin) therapy is associated with hepatic venoocclusive disease in patients who have not received stem cell transplantation
2001 • 278 citations
Fludarabine: a new agent with major activity against chronic lymphocytic leukemia
1989 • 260 citations
Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia.
1991 • 255 citations
Hepatic sinusoidal obstruction after gemtuzumab ozogamicin (Mylotarg) therapy
2002 • 240 citations
Humanized CD52 monoclonal antibody campath‐1H as first‐line treatment in chronic lymphocytic leukaemia
1996 • 239 citations
Expression of normal myeloid-associated antigens by acute leukemia cells
1986 • 227 citations
A phase I study of an anti-CD22-deglycosylated ricin A chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapy
1993 • 221 citations
Immunotoxins in cancer therapy
1999 • 214 citations
Treatment of T-cell prolymphocytic leukemia with human CD52 antibody.
1997 • 210 citations
A phase I study of an anti-CD22-deglycosylated ricin A chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapy
1993 • 185 citations
Diagnostic application of two-color flow cytometry in 161 cases of hairy cell leukemia
1993 • 181 citations
Monoclonal antibody therapy of cancer.
1999 • 96 citations
Cytotoxic activity of disulfide-stabilized recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) toward fresh malignant cells from patients with B-cell leukemias.
2000 • 88 citations
Complete regression of human B-cell lymphoma xenografts in mice treated with recombinant anti-CD22 immunotoxin RFB4(dsFv)-PE38 at doses tolerated by cynomolgus monkeys
1999 • 87 citations
Hepatic venoocclusive disease in autologous bone marrow transplantation of solid tumors and lymphomas.
1990 • 72 citations
Principles of radioimmunotherapy for hematologists and oncologists.
2000 • 63 citations
Heterogeneity and Clinical Relevance of the Intensity of CD20 and Immunoglobulin Light-Chain Expression in B-Cell Chronic Lymphocytic Leukemia
1996 • 40 citations
Diagnostic relevance of peripheral blood immunocytochemistry in hairy cell leukaemia.
1995 • 24 citations
Preliminary report of the safety and efficacy of gemtuzumab ozogamicin (Mylotarg (R)) given in combination with cytarabine and daunorubicin in patients with acute myeloid leukemia
2001 • 16 citations
Deleted Work
1955 • 0 citations
Cited By (0)
No citing papers found in database